Bank of New York Mellon’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.18M | Buy |
103,773
+13,788
| +15% | +$156K | ﹤0.01% | 3036 |
|
2025
Q1 | $598K | Sell |
89,985
-3,210
| -3% | -$21.3K | ﹤0.01% | 3339 |
|
2024
Q4 | $1.03M | Buy |
93,195
+1,330
| +1% | +$14.7K | ﹤0.01% | 3131 |
|
2024
Q3 | $1.13M | Sell |
91,865
-24,027
| -21% | -$295K | ﹤0.01% | 3066 |
|
2024
Q2 | $1.57M | Buy |
115,892
+25,988
| +29% | +$351K | ﹤0.01% | 2936 |
|
2024
Q1 | $1.21M | Sell |
89,904
-8,424
| -9% | -$114K | ﹤0.01% | 3040 |
|
2023
Q4 | $517K | Sell |
98,328
-8,926
| -8% | -$47K | ﹤0.01% | 3529 |
|
2023
Q3 | $423K | Buy |
107,254
+2,926
| +3% | +$11.5K | ﹤0.01% | 3635 |
|
2023
Q2 | $1.11M | Buy |
104,328
+14,746
| +16% | +$157K | ﹤0.01% | 3133 |
|
2023
Q1 | $746K | Sell |
89,582
-1,193
| -1% | -$9.94K | ﹤0.01% | 3269 |
|
2022
Q4 | $838K | Buy |
90,775
+10,595
| +13% | +$97.8K | ﹤0.01% | 3278 |
|
2022
Q3 | $1.03M | Buy |
80,180
+8,556
| +12% | +$110K | ﹤0.01% | 3188 |
|
2022
Q2 | $947K | Buy |
71,624
+8,926
| +14% | +$118K | ﹤0.01% | 3239 |
|
2022
Q1 | $1.32M | Buy |
62,698
+837
| +1% | +$17.6K | ﹤0.01% | 3142 |
|
2021
Q4 | $1.48M | Buy |
61,861
+1,924
| +3% | +$46.2K | ﹤0.01% | 3158 |
|
2021
Q3 | $1.53M | Buy |
59,937
+5,565
| +10% | +$142K | ﹤0.01% | 3161 |
|
2021
Q2 | $1.83M | Buy |
54,372
+3,192
| +6% | +$107K | ﹤0.01% | 3038 |
|
2021
Q1 | $1.99M | Sell |
51,180
-3,055
| -6% | -$119K | ﹤0.01% | 2926 |
|
2020
Q4 | $3.36M | Buy |
54,235
+5,281
| +11% | +$327K | ﹤0.01% | 2541 |
|
2020
Q3 | $1.64M | Sell |
48,954
-2,090
| -4% | -$70K | ﹤0.01% | 2780 |
|
2020
Q2 | $1.22M | Sell |
51,044
-6,218
| -11% | -$148K | ﹤0.01% | 2984 |
|
2020
Q1 | $1.31M | Buy |
57,262
+23,581
| +70% | +$540K | ﹤0.01% | 2785 |
|
2019
Q4 | $954K | Buy |
33,681
+9,086
| +37% | +$257K | ﹤0.01% | 3268 |
|
2019
Q3 | $529K | Buy |
+24,595
| New | +$529K | ﹤0.01% | 3500 |
|